Blog
Here's How I'm Investing My Stimulus Check
When I checked my bank account last week, I noticed a large deposit. In the bustle surrounding the COVID-19 pandemic, I hadn't paid attention to when and how the government's stimulus checks would
Quest Diagnostics Rolls Out Home COVID-19 Antibody Test for Purchase Online
Medical testing specialist Quest Diagnostics (NYSE: DGX) has rolled out a product that is likely to find a large customer base in a hurry. The company announced Tuesday that its QuestDirect unit is
Is Domino's Pizza Stock a Buy?
When most investors think about high-growth stocks, their first impulse is to look to innovative young technology companies offering the latest cutting-edge capabilities. Yet the stock market
Even the Top U.S. Oil Fund Is Becoming Bearish About Oil
The United States Oil (NYSEMKT: USO) exchange-traded fund (ETF) has been making big news lately. As the largest exchange-traded fund with direct exposure to the price of U.S. oil, shares have fallen
After Dragging Its Feet, Apple Music Finally Gets a Web App
Apple's (NASDAQ: AAPL) Apple Music has finally erased one of the biggest user-facing differences between itself and competitors like Spotify. At long last, users can access an officially released
Microsoft’s Earnings: 2 COVID-19 Questions That Need Answering
Microsoft's (NASDAQ: MSFT) cloud business is booming, as work-at-home becomes the new normal amid the COVID-19 pandemic. At the same time, the rest of its operations are being hurt by the same
Better Buy: OrganiGram Holdings vs. Canopy Growth
Comparing Canopy Growth (NYSE: CGC) against OrganiGram Holdings (NASDAQ: OGI) is a bit of a David vs. Goliath match-up. The former is the industry leader. The latter is still a fairly small player
Should You Panic About Target’s Next Earnings Report?
I often refer to Target (NYSE: TGT) as the "good student" of retail, with annual revenue gains since 2017, strong owned brands, and growth in key areas like digital sales and grocery. But these days
Is Brookfield Asset Management Stock a Buy?
Like most other stocks, Brookfield Asset Management (NYSE: BAM) has suffered the ups and downs that have come with the coronavirus pandemic over the past two months. But its carefully organized
3 Dividend Stocks to Bankroll Your Retirement
It's almost impossible for companies out there to avoid being impacted by COVID-19 in some way, even if they aren't stricken by the pandemic directly. That has investors worried and not
Should You Buy Stock Now in This New Coronavirus Drug Developer?
Large and small drug developers and academic researchers are furiously testing and hoping to find one or more treatments for COVID-19. While novel drugs aimed specifically at the coronavirus could
3 Unknown but Amazing Dividend Stocks
Investments that pay, and grow, dividends can be a reliable path to creating long-term wealth. Retirees may want dividends for current income needs, but they can also pay off in a big way for young
3 Technology Stocks I'd Buy Right Now
The COVID-19 pandemic ushered in market volatility, and conventional wisdom says to only invest in companies providing essential services. The stocks of many essential retailers and consumer staples
How Risky Is FuelCell Energy Stock?
Tracing its history back more than 50 years, FuelCell Energy (NASDAQ: FCEL) is one of the most recognizable names in the renewable energy niche of fuel cell technology. And while the company has
Is Your Retirement Plan Down Because of COVID-19? Here's How to Keep Calm.
It's no secret that COVID-19 has been battering the U.S. economy since cases started spreading rapidly in March. Not only have millions of Americans lost their jobs, but the stock market has taken
Is Travelers Stock a Buy?
The past couple of months have been miserable for the financials sector due to fallout from the coronavirus pandemic. Despite a favorable interest rate backdrop, stocks for companies in this sector
3 Pot Stocks That Aren't as Cheap as They Appear
Throughout much of 2017, most of 2018, and the first quarter of 2019, marijuana stocks were virtually unstoppable. Promises of top-tier production, partnerships, and high-margin derivative products
3 Recent IPOs to Add to Your Watchlist
Savvy investors know that keeping a watchlist is one of the most valuable strategies that can be employed, since it can be extremely frustrating -- and costly -- when investors find themselves with
Better Buy: Cara Therapeutics vs. Sangamo Therapeutics
You can't lump all clinical-stage biotechs together. Take Cara Therapeutics (NASDAQ: CARA) and Sangamo Therapeutics (NASDAQ: SGMO), for example. The two biotechs are about as different as night and
Is Fate Therapeutics a Buy?
The therapeutic qualities of living cells have tremendous potential to improve patient outcomes for a broad range of ailments, from cancers to autoimmune diseases. Engineering cell therapies isn't
Here's Zebra Technologies' Q1 Report In Black and White
Data management specialist Zebra Technologies (NASDAQ: ZBRA) reported first-quarter earnings early Tuesday morning. The company had plenty of orders on tap but the coronavirus outbreak led to
These Stocks Could Lead the Post-Coronavirus Contactless Payment Evolution
If you're going to think twice before touching anything outside of your home once the coronavirus outbreak is beat, you're not alone. Ernst & Young's most recent EY Future Consumer Index survey said
Better Marijuana Stock: Canopy Growth vs. Tilray
Canopy Growth (NYSE: CGC) and Tilray (NASDAQ: TLRY) rank as two of the best-known Canadian cannabis producers. Both companies have forged key partnerships. Both companies have expanded outside of
FireEye Inc (FEYE) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
FireEye Inc (NASDAQ: FEYE)Q1 2020 Earnings CallApr 28, 2020, 5:00 p.m. ET
Operator
Source Fool.com
Something Worse Than the Coronavirus Could Be on the Way -- Here's How You Can Invest Accordingly
It could get worse.
I know, those are four words that you don't want to hear right now. And, unfortunately, I'm not referring to the state of affairs relating to the novel coronavirus or the


